Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Curto

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
Archives of Biochemistry and Biophysics|March 21, 2020
Structural analysis of a natural apolipoprotein A-I variant (L60R) associated with amyloidosisGisela M Gaddi, Romina A Gisonno, Silvana A Rosú, et al.
Biochimica Et Biophysica Acta. General Subjects|January 7, 2020
Fibrillar conformation of an apolipoprotein A-I variant involved in amyloidosis and atherosclerosisRomina A Gisonno, Eduardo D Prieto, Juan P Gorgojo, et al.
Organic & Biomolecular Chemistry|March 5, 2014
Support of academic synthetic chemistry using separation technologies from the pharmaceutical industryErik L Regalado, Marisa C Kozlowski, John M Curto, et al.
Hepatology (Baltimore, Md.)|December 25, 2007
Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) TrialLeonard B Seeff, Teresa M Curto, Gyongyi Szabo, et al.
Bioorganic & Medicinal Chemistry|March 28, 2003
Catechols from abietic acid synthesis and evaluation as bioactive compoundsB Gigante, C Santos, A M Silva, et al.
Gastroenterology|September 22, 2009
Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis CMarc G Ghany, Anna S F Lok, James E Everhart, et al.
Gastroenterology|October 14, 2008
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver diseaseAnna S Lok, Leonard B Seeff, Timothy R Morgan, et al.
Hepatology (Baltimore, Md.)|September 26, 2008
Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis CChihiro Morishima, Timothy R Morgan, James E Everhart, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2023
6-Azaspiro[2.5]octanes as small molecule agonists of the human glucagon-like peptide-1 receptorGary E Aspnes, Scott W Bagley, Steven B Coffey, et al.
Hepatology (Baltimore, Md.)|August 14, 2009
Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis CNeal D Freedman, James E Everhart, Karen L Lindsay, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Archives of Biochemistry and Biophysics|March 21, 2020
Structural analysis of a natural apolipoprotein A-I variant (L60R) associated with amyloidosisGisela M Gaddi, Romina A Gisonno, Silvana A Rosú, et al.
Biochimica Et Biophysica Acta. General Subjects|January 7, 2020
Fibrillar conformation of an apolipoprotein A-I variant involved in amyloidosis and atherosclerosisRomina A Gisonno, Eduardo D Prieto, Juan P Gorgojo, et al.
Organic & Biomolecular Chemistry|March 5, 2014
Support of academic synthetic chemistry using separation technologies from the pharmaceutical industryErik L Regalado, Marisa C Kozlowski, John M Curto, et al.
Hepatology (Baltimore, Md.)|December 25, 2007
Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) TrialLeonard B Seeff, Teresa M Curto, Gyongyi Szabo, et al.
Bioorganic & Medicinal Chemistry|March 28, 2003
Catechols from abietic acid synthesis and evaluation as bioactive compoundsB Gigante, C Santos, A M Silva, et al.
Gastroenterology|September 22, 2009
Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis CMarc G Ghany, Anna S F Lok, James E Everhart, et al.
Gastroenterology|October 14, 2008
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver diseaseAnna S Lok, Leonard B Seeff, Timothy R Morgan, et al.
Hepatology (Baltimore, Md.)|September 26, 2008
Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis CChihiro Morishima, Timothy R Morgan, James E Everhart, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2023
6-Azaspiro[2.5]octanes as small molecule agonists of the human glucagon-like peptide-1 receptorGary E Aspnes, Scott W Bagley, Steven B Coffey, et al.
Hepatology (Baltimore, Md.)|August 14, 2009
Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis CNeal D Freedman, James E Everhart, Karen L Lindsay, et al.
Pageof 15